Art
J-GLOBAL ID：202002281830689807
Reference number：20A0970583
免疫チェックポイント阻害薬~知って実践!免疫関連有害事象マネジメント~「だるいのです」を見過ごさない!-倦怠感にはもっと突っ込んでアセスメントを~
Author (1)：
Material：
Volume：
25
Issue：
4
Page：
309-312
Publication year：
May. 01, 2020
JST Material Number：
L3817A
ISSN：
1342-0569
Document type：
Article
Country of issue：
Japan (JPN)
Language：
JAPANESE (JA)
Reference (9)：
-
Bayer V et al: Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice. Clin J Oncol Nurs 21(2 Suppl): 13-21, 2017
-
Brahmer JR et al: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy. American Society of Clinical Oncology Clinical Practice Guideline: J Clin Oncol 36(17): 1714-1768, 2018
-
Joshi MN et al: Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: Clinical review. Clin Endocrinol 85: 331-339, 2016
-
Pirschel C: Using CTCAE to Report Immunotherapy Adverse Events, ONS VOICE, 2018
-
Wood LS et al: Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients. Clin J Oncol Nurs 23 (3) : 271-280, 2019
ｍore...
Terms in the title (5)：
Terms in the title
Keywords automatically extracted from the title.
,
,
,
,
Return to Previous Page
